Advertisement

Topics

Elixir Medical Corporation Company Profile

13:57 EDT 21st September 2017 | BioPortfolio

Elixir Medical is developing a wide range of drug and device platforms for vascular therapies. These include drug eluting stent systems with durable and bioabsorbable polymers, and fully bioresorbable drug eluting stent systems.


News Articles [1048 Associated News Articles listed on BioPortfolio]

Canadian Innovation: Hydropothecary Corporation set to release Canada's first-ever medical cannabis mouth spray

GATINEAU, QC--(Marketwired - July 25, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) today announced it will soon launch Elixir No. 1 Canada's only legal medical marijuana sublingual (und...

#jobs #lifescience EMBL: ELIXIR Junior Project Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: EMBL: ELIXIR Junior Project Manager . Competitive Salary: EMBL: ELIXIR Junior...

Elixir Medical to Release Five-year DESolve Nx Trial Data, Showcase Next-Generation Coronary and SFA Bioresorbable Scaffold Systems at EuroPCR 2017

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will release at EuroPCR in...

Elixir Medical Announces Outstanding 5-Year Clinical Data For CE Mark-Approved Desolve Novolimus Eluting Bioresorbable Coronary Scaffold System

  Life Sciences Jobs   ...

Hydropothecary Announces Stock Option Grants to Officers and Employees

GATINEAU, QC--(Marketwired - September 08, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) announces that it has made a grant of stock options under its stock opti...

Hydropothecary announces kosher certification on processed medical marijuana products

GATINEAU, QC--(Marketwired - September 19, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce its processed medical marijuana products have be...

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

PubMed Articles [2741 Associated PubMed Articles listed on BioPortfolio]

ELIXIR-UK role in bioinformatics training at the national level and across ELIXIR.

ELIXIR-UK is the UK node of ELIXIR, the European infrastructure for life science data. Since its foundation in 2014, ELIXIR-UK has played a leading role in training both within the UK and in the ELIXI...

Developing a strategy for computational lab skills training through Software and Data Carpentry: Experiences from the ELIXIR Pilot action.

Quality training in computational skills for life scientists is essential to allow them to deliver robust, reproducible and cutting-edge research. A pan-European bioinformatics programme, ELIXIR, has ...

ReGaTE, Registration of Galaxy Tools in Elixir.

Bioinformaticians routinely use multiple software tools and data sources in their day-to-day work, and have been guided in their choices by a number of cataloguing initiatives. The ELIXIR Tools and Da...

Paine's Celery Compound: Celery Seed Bracer or Cocaine Elixir?

Nurturing virtues of the medical profession: does it enhance medical students' empathy?

To examine if the empathy levels of first-year medical students are amenable to didactic interventions idealized to promote values inherent to medical professional identity.

Clinical Trials [1362 Associated Clinical Trials listed on BioPortfolio]

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study With a Single-Arm Registry "EXCELLA II STUDY"

Randomized Study To evaluate the safety and effectiveness of the Elixir Medical Novolimus-Eluting Coronary Stent System with Durable Polymer through the assessment of clinical, angiographi...

Efficacy and Safety of Ginseng Extract on Improvement of Bone Metabolism in Menopausal Women

Recently, osteoprosis has been recognized as a serious health problem in the elderly, it has also increased in young • middle-aged layer. Ginseng is history 2, 000 years Korean typical h...

A Phase I Randomized Dose/Formulation Comparison Study of SC-52151

PRIMARY: To evaluate the safety, tolerability, pharmacokinetics, and ethanol exposure of two dose regimens and formulations of SC-52151. SECONDARY: To evaluate the preliminary anti-HIV ac...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Chart Review Study of Medical Abortion

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal miso...

Companies [1335 Associated Companies listed on BioPortfolio]

Elixir, pc

Elixir, pc is a Michigan professional corporation and the embodiment of a unique concept in pharmaceutical staffing. Elixir, pc serves pharmacies as well as qualified pharmacy professionals by providi...

Elixir Pharmaceuticals, Inc.

Elixir is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic and neurodegenerative diseas...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Elixir Medical Corporation

Elixir Medical is developing a wide range of drug and device platforms for vascular therapies. These include drug eluting stent systems with durable and bioabsorbable polymers, an...

Elixir Bio-Tech Inc.

More Information about "Elixir Medical Corporation" on BioPortfolio

We have published hundreds of Elixir Medical Corporation news stories on BioPortfolio along with dozens of Elixir Medical Corporation Clinical Trials and PubMed Articles about Elixir Medical Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elixir Medical Corporation Companies in our database. You can also find out about relevant Elixir Medical Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record